43 results about "Acyclic Hydrocarbons" patented technology

For the purpose of providing a urethane(meth)acrylate excellent in emulsifiability in water and a production method thereof, and a light curable aqueous emulsion using the urethane(meth)acrylate having a low viscosity and excellent in the curability, provided is a urethane(meth)acrylate being represented by the following general formula (1) and having a weight average molecular weight of 1,000 to 10,000:A1-O—(CONH—B1-NHCOO—C1-O)n-CONH—B1-NH—COO-D1  (1)wherein in formula (1), n represents a natural number of 1 to 30, A1 represents a residue of a hydroxyl group-containing (meth)acrylate, B1 represents a residue of diisocyanate, C1 represents a residue of a diol of an acyclic hydrocarbon or a cyclic hydrocarbon, and D1 represents a residue of a polyoxyalkylene glycol monoalkyl ether.

The invention relates to a fountain solution composition for lithographic printing and heat-set offset rotary printing process. The inventive objective is to provide a method for improvement of blanket pilling, more particularly a method for improvement of blanket pilling in view of fountain solution composition. The objective is implemented by the following technical means: a fountain solution composition for lithographic printing is characterized by comprising at least one acyclic hydrocarbon diol compound having 6 to 8 carbon atoms in total and two OH groups, the two OH groups are respectively bind on the carbon atoms at 1- and 2- positions.

Provided is a process for preparing 10-chloro-9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide (DOPO-C) compound, the process having steps of:reacting a liquid chlorinating agent and 9,10-dihydro-10-hydroxy-9-oxa 10-phosphaphenanthrene 10-oxide compound represented by formula (B) to form a mixture, the mixture comprises DOPO-C compound represented by formula (A) and an unreacted liquid chlorinating agent,separating the DOPO-C compound and the unreacted liquid chlorinating agent from the mixture to obtain the DOPO-C compound; wherein X1, X2, and X3 are each independently selected from the group consisting of hydrogen atom, hydroxyl group, cyano group, sulfonic acid group, sulfonate ester group represented by —SO3R1, halogen atom, alkoxy group represented by —OR2, acyclic hydrocarbon group having 1 to 8 carbon atoms, cyclic alkyl group having 3 to 8 carbon atoms, aryl group, heteroaryl group, and arylalkyl group, wherein R1 and R2 are each an acyclic hydrocarbon group having 1 to 8 carbon atoms.

The invention provides compounds that are useful in the treatment of hepatitis C virus (HCV) infections. The compounds have the formula (1):or a salt, N-oxide, tautomer or stereoisomer thereof, wherein A is CH or N; E is CH or N;R1 is selected from:an optionally substituted acyclic C1-8 hydrocarbon group wherein one carbon atom of the acyclic C1-8 hydrocarbon group may optionally be replaced by O, S, NRc, S(O) or SO2, or two adjacent carbon atoms of the acyclic C1-8 hydrocarbon group may optionally be replaced by CONRc, NRcCO, NRcSO2 or SO2NRc provided that in each case at least one carbon atom of the acyclic C1-8 hydrocarbon group remains; andan optionally substituted monocyclic carbocyclic or heterocyclic group of 3 to 7 ring members, of which 0, 1, 2, 3 or 4 are heteroatom ring members selected from O, N and S;R2 is hydrogen or X—R8;X is a C1-8 alkanediyl group wherein one carbon atom of the C1-8 alkanediyl group may optionally be bonded to a —CH2—CH2— moiety to form a cyclopropane-1,1-diyl group or two adjacent carbon atoms of the C1-8 alkanediyl group may optionally be bonded to a —(CH2)n moiety, where n is 1 to 5, to form a C3-7-cycloalkane-1,2-diyl group;R3 is an optionally substituted 3- to 10-membered monocyclic or bicyclic carbocyclic or heterocyclic ring containing 0-3 heteroatom ring members selected from N, O and S;R4 is hydrogen or R4a wherein R4a is halogen; cyano; C1-4 alkyl; fluoro-1-4 alkyl; C1-4 alkoxy; fluoro-C1-4 alkoxy; hydroxy-C1-4 alkyl; or C1-2 alkoxy-C1-4 alkyl;R5 is hydrogen or R5a wherein R5a is selected from C1-2 alkyl optionally substituted with fluorine; C1-3 alkoxy optionally substituted with fluorine; halogen; cyclopropyl; and cyano;R8 is hydroxy or C(═O)NR10R11; provided that when R8 is hydroxy, there are at least two carbon atoms in line between the hydroxy group and the nitrogen atom to which X is attached;R10 is hydrogen or C1-4 alkyl; andR11 is hydrogen; amino-C2-4 alkyl or hydroxy-C2-4 alkyl;but excluding the compounds 1-(3-benzoylphenyl)-ethylamine and 1-(3-furan-2-oylcarbonylphenyl)-ethylamine.

The invention relates to a fountain solution composition for lithographic printing and a heatset offset rotary printing process. The invention provides a method of improving mackintosh pilling, particularly a method of improving the mackintosh pilling from viewpoints of the fountain solution composition. The aim is realized through the following means that: a fountain solution composition for lithographic printing is characterized by comprising at least one acyclic hydrocarbon diol compound, having 9 carbon atoms in total and two -OH groups, wherein the number of carbon atoms existing between said two -OH groups via minimal distance is from 2 to 6.

Bitumen pellets including at least one chemical additive chosen from: a compound of general formula (I): R1-(COOH)z in which R1 is a linear or branched, saturated or unsaturated hydrocarbon-based chain including from 4-68 carbon atoms, and z is an integer ranging from a compound of general formula (II): R—(NH)nCONH—(X)m-NHCO(NH)n-R′ in which: R and R′ are identical or different, contain a saturated or unsaturated, linear or branched, cyclic or acyclic hydrocarbon-based chain having from 1-22 carbon atoms and optionally including heteroatoms and / or rings having from 3-12 atoms and / or heterocycles having from 3-12 atoms; X contains a saturated or unsaturated, linear or branched, cyclic or acyclic hydrocarbon-based chain having from 1-22 carbon atoms and optionally including one or more heteroatoms and / or rings having from 3-12 atoms and / or heterocycles having from 3-12 atoms; n and m are integers having, independently of one another, a value of 0 or of 1.

The present invention provides an electrophotographic toner binder containing, as a main component, a polymer whose constituent monomer is a monomer having an ethylenically unsaturated bond, the electrophotographic toner binder being excellent in low-temperature fixability, hot-offset resistance, and storage stability. The present invention provides an electrophotographic toner binder containing a polymer (A) containing a monomer (a) and a monomer (x) different from the monomer (a) as essential constituent monomers, wherein the monomer (a) is a (meth)acrylate having a C18-C36 acyclic hydrocarbon group, the polymer (A) has an acid value of 40 or less, and the polymer (A) satisfies the following relational expression (1):1.1 (cal / cm3)0.5≤|SP(x)−SP(a)|≤8.0 (cal / cm3)0.5  relational expression (1):wherein SP(a) is the SP value of a structural unit derived from the monomer (a) constituting the polymer (A); andSP(x) is the SP value of a structural unit derived from the monomer (x) different from the monomer (a) constituting the polymer (A).

A fountain solution composition for lithographic printing characterized by comprising at least one acyclic hydrocarbon diol compound, having 6 to 8 carbon atoms in total and two —OH groups, wherein said two —OH groups bind to carbon atoms at 1- and 2-positions, respectively; said fountain solution composition can be used to improve blanket piling.

This invention relates to processes and systems for converting acyclic hydrocarbons to alkenes, cyclic hydrocarbons and / or aromatics, for example converting acyclic C5 hydrocarbons to cyclopentadiene in a reactor system. The process includes contacting a feedstock comprising acyclic hydrocarbons with a catalyst material and an inert material to convert at least a portion of the acyclic hydrocarbons to a first effluent comprising alkenes, cyclic hydrocarbons and / or aromatics. In particular, the catalyst material and the inert material have a different average diameter and / or density providing varying fluidization behavior in the reactor.

This invention relates to a process for converting acyclic C5 hydrocarbons to cyclopentadiene including: providing to the at least one adiabatic reaction zone a feedstock comprising acyclic C5 hydrocarbons at a temperature, Ti, wherein the at least one adiabatic reaction zone comprises a first particulate material comprising catalyst material; contacting the feedstock and the first particulate material in the at least one adiabatic reaction zone under reaction conditions to convert at least a portion of the acyclic C5 hydrocarbons to a first effluent comprising cyclopentadiene intermediates, unconverted acyclic C5 hydrocarbons, and, optionally, cyclopentadiene; heating the first effluent to a temperature, T2; providing the first effluent to the at least one diabatic reaction zone; and contacting the first effluent and a second particulate material comprising catalyst material in the at least one diabatic reaction zone under reaction conditions to convert at least a portion of the cyclopentadiene intermediates and the unconverted acyclic C5 hydrocarbons to a second effluent comprising cyclopentadiene.

This invention relates to processes and systems for converting acyclic hydrocarbons to alkenes, cyclic hydrocarbons and / or aromatics, for example converting acyclic C5 hydrocarbons to cyclopentadiene in a reactor system. The process includes contacting a feedstock comprising acyclic hydrocarbons with a catalyst material in at least one reaction zone to convert at least a portion of the acyclic hydrocarbons to a first effluent comprising alkenes, cyclic hydrocarbons and / or aromatics. A co-feed comprising H2, C1-C4 alkanes and / or C1-C4 alkenes may also be provided to the at least one reaction zone.

A process conducts organic reactions in a standalone laboratory scale solar photo thermo chemical reactor. For organic reactions require elevated temperature, light and mechanical agitation, all three energy forms can be simultaneously derived from solar radiation. Organic synthesis, such as bromination of toluene derivatives (benzylic bromination), bromination of cyclic acyclic hydrocarbon and oxidative cyclization of N-phenylethyl benzamide through bromination were successfully conducted in such reactors.

The invention relates to processes and systems for converting acyclic hydrocarbons to alkenes, cyclic hydrocarbons and / or aromatics, for example converting acyclic C5 hydrocarbons to cyclopentadiene in a reactor system. The process includes contacting a feedstock comprising acyclic hydrocarbons with a catalyst material in at least one reaction zone to convert at least a portion of the acyclic hydrocarbons to a first effluent comprising alkenes, cyclic hydrocarbons and / or aromatics. A co-feed comprising H2, C1-C4 alkanes and / or C1-C4 alkenes may also be provided to the at least one reaction zone.

The present invention relates to a lubricant composition containing: a base oil (A); at least one kind of calcium-based detergent (B) selected from (B1) calcium sulfonate having a base number of 5.00 mgKOH / g or more and 100 mgKOH / g or less, (B2) calcium salicylate having a branched acyclic hydrocarbon group, and (B3) overbased calcium phenate having a branched acyclic hydrocarbon group; and at least one kind of ashless detergent (C) selected from (C1) a hindered amine compound having one piperidine-derived backbone in a molecule, and (C2) a specific diethanolamine compound. In the lubricant composition, the calcium atom content is 100 ppm by mass or more and 600 ppm by mass or less with respect to the total mass of the lubricant composition, and the ratio (NC / CaB) of the nitrogen atom content (NC) of the ashless detergent (C) to the calcium atom content (CaB) of the calcium-based detergent (B) is 1.3 to 3.1 as a mass ratio.

A compound of the formula (I) wherein R represents a straight or branched, primary or secondary acyclic hydrocarbyl C3-C15 group, which can be saturated or unsaturated, or a straight or branched, primary or secondary acyclic hydrocarbyl C3-C15 group, which can be saturated or unsaturated and wherein one or more of hydrogen atoms is replaced with fluorine atom; X represents hydrogen atom or halogen atom, and * denotes chiral center, and salts thereof. The compound is useful for the treatment of diseases mediated by GPR40, in particular type II diabetes. (I)

Electrolytes comprising at least one lithium salt and at least two ionic liquids, at least one of which is an ionic liquid resulting from the association of at least one cation complying with the following formula (I):In which: R1 is an acyclic hydrocarbon group; n is an integer ranging from 0 to 3; m is an integer ranging from 1 to 4; and at least one Y anion.

Methods for treating a patient suffering from neural cell injury, the method comprising administering to the patient an effective amount of a HIF prolyl-4-hydroxylase inhibiting compound having the following general formula (1) wherein R1 is a cyclic group containing at least three and up to seven carbon atoms and optionally containing one or more heteroatoms selected from O, N, and S, and optionally attached to the shown carbon atom by a linking group; R2 is independently selected from said cyclic groups of R1 and acyclic hydrocarbon groups R5 containing up to twenty carbon atoms; R3 is selected from hydrogen atom and hydrocarbon groups containing up to six carbon atoms; R6 and R7 are independently selected from hydrogen atom, hydrocarbon groups containing up to three carbon atoms, halogen atom, and polar groups, as well as methylene-linked versions thereof; and t is 0 or 1.